Clinical trials
Terminated Peripheral Arterial Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 9 |
| 2015 | 7 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 3 |
| 2019 | 10 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 81 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 2 |
| Catharina Ziekenhuis Eindhoven | 2 |
| Genovate Biotechnology Co., Ltd., | 2 |
| Imperial College London | 2 |
| Ixaka Ltd | 2 |
| The Cleveland Clinic | 2 |
| University Hospital, Angers | 2 |
| University Hospital, Toulouse | 2 |
| University of Michigan | 2 |
| Wake Forest University Health Sciences | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peripheral Arterial Disease | 81 |
| Peripheral Vascular Diseases | 14 |
| Intermittent Claudication | 12 |
| Chronic Limb-Threatening Ischemia | 11 |
| Atherosclerosis | 5 |
| Cardiovascular Diseases | 5 |
| Arterial Occlusive Diseases | 4 |
| Diabetes Mellitus | 4 |
| Diabetes Mellitus, Type 2 | 4 |
| Vascular Diseases | 4 |
Trials
Showing 76 to 81 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.